• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缅甸间日疟原虫 VK210 和 VK247 亚型的流行情况。

Prevalence of Plasmodium vivax VK210 and VK247 subtype in Myanmar.

机构信息

Division of Malaria and Parasitic diseases, Korea Centers for Disease Control and Prevention, Seoul 122-701, Republic of Korea.

出版信息

Malar J. 2010 Jul 9;9:195. doi: 10.1186/1475-2875-9-195.

DOI:10.1186/1475-2875-9-195
PMID:20615261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2914060/
Abstract

BACKGROUND

Plasmodium vivax is divided into two subtypes, a dominant form, VK210 and a variant form, VK247. This division is dependent on the amino acid composition of the circumsporozoite (CS) protein. In this study, the prevalence of the VK247 variant form of P. vivax was investigated in Myanmar.

METHODS

The existence of malaria parasites in blood samples was determined by microscopic examination, polymerase chain reaction (PCR) and DNA hybridization assays. To test for antibodies against P. vivax and Plasmodium falciparum in blood samples, an indirect immunofluorescence antibody test (IFAT) was performed using asexual blood antigens. An enzyme-linked immunosorbent assay with synthetic VK210 and VK247 antigens was carried out to discriminate between the P. vivax subtypes.

RESULTS

By thick smear examination, 73 (n=100) patients were single infected with P. vivax, one with P. falciparum and 13 with both species. By thin smear, 53 patients were single infected with P. vivax, eight with only P. falciparum and 16 with both. Most of the collected blood samples were shown to be P. vivax positive (n=95) by PCR. All cases that were positive for P. falciparum by PCR (n=43) were also positive for P. vivax. However, 52 cases were single infected with P. vivax. IFAT showed antibody titres from 1:32 to 1:4,096. Additionally, using specific antibodies for VK210 and VK247, ELISA showed that 12 patients had antibodies for only the VK210 subtype, 4 patients had only VK247 subtype antibodies and 21 patients had antibodies for both subtypes. Using a DNA hybridization test, 47 patients were infected with the VK210 type, one patient was infected with VK247 and 23 patients were infected with both subtypes.

CONCLUSIONS

The proportion of the VK247 subtype in Myanmar was 43.1% (n=25) among 58 positive cases by serodiagnosis and 25.6% (n=24) among 94 positive cases by genetic diagnosis. In both diagnostic methods, the infection status of malaria patients is highly diverse with respect to malaria species, and multiple clonal infections are prevalent in Myanmar. Therefore, the complexity of the infection should be considered carefully when diagnosing malaria in Myanmar.

摘要

背景

间日疟原虫分为两种亚型,一种是主要形式 VK210,另一种是变异形式 VK247。这种划分取决于环子孢子蛋白的氨基酸组成。在这项研究中,调查了缅甸间日疟原虫 VK247 变异型的流行情况。

方法

通过显微镜检查、聚合酶链反应(PCR)和 DNA 杂交试验来确定血液样本中疟原虫的存在。为了检测血液样本中对间日疟原虫和恶性疟原虫的抗体,采用间接免疫荧光抗体试验(IFAT),使用无性血抗原。通过酶联免疫吸附试验,用合成的 VK210 和 VK247 抗原来区分间日疟原虫的亚型。

结果

通过厚涂片检查,100 例患者中有 73 例(n=100)单独感染间日疟原虫,1 例感染恶性疟原虫,13 例同时感染两种疟原虫。通过薄涂片,53 例患者单独感染间日疟原虫,8 例仅感染恶性疟原虫,16 例同时感染两种疟原虫。PCR 显示大多数采集的血液样本均为间日疟原虫阳性(n=95)。所有通过 PCR 检测为恶性疟原虫阳性的病例(n=43)也均为间日疟原虫阳性。然而,52 例为单独感染间日疟原虫。IFAT 显示抗体滴度为 1:32 至 1:4,096。此外,使用针对 VK210 和 VK247 的特异性抗体,ELISA 显示 12 例患者只有 VK210 型抗体,4 例患者只有 VK247 型抗体,21 例患者同时具有两种亚型的抗体。通过 DNA 杂交试验,47 例患者感染 VK210 型,1 例患者感染 VK247 型,23 例患者同时感染两种亚型。

结论

在血清学诊断的 58 例阳性病例中,间日疟原虫 VK247 亚型的比例为 43.1%(n=25),在基因诊断的 94 例阳性病例中,间日疟原虫 VK247 亚型的比例为 25.6%(n=24)。在这两种诊断方法中,疟疾病例的疟疾物种感染状况高度多样化,并且多重克隆感染在缅甸很普遍。因此,在诊断缅甸的疟疾时,应仔细考虑感染的复杂性。

相似文献

1
Prevalence of Plasmodium vivax VK210 and VK247 subtype in Myanmar.缅甸间日疟原虫 VK210 和 VK247 亚型的流行情况。
Malar J. 2010 Jul 9;9:195. doi: 10.1186/1475-2875-9-195.
2
Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar.缅甸曼德勒居民对间日疟原虫和恶性疟原虫抗原的抗体反应比较。
Malar J. 2011 Aug 6;10:228. doi: 10.1186/1475-2875-10-228.
3
High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea.高通量分子诊断环子孢子变异体 VK210 和 VK247 检测 Papua New Guinea 疟疾流行区复杂的间日疟原虫感染。
Infect Genet Evol. 2011 Mar;11(2):391-8. doi: 10.1016/j.meegid.2010.11.010. Epub 2010 Dec 13.
4
Serologic and genetic characterization of Plasmodium vivax from whole blood-impregnated filter paper discs.来自全血浸渍滤纸圆盘的间日疟原虫的血清学和遗传学特征
Am J Trop Med Hyg. 1992 Apr;46(4):473-9. doi: 10.4269/ajtmh.1992.46.473.
5
High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar.缅甸间日疟原虫野外分离株的遗传多样性频率较高。
Acta Trop. 2009 Jan;109(1):30-6. doi: 10.1016/j.actatropica.2008.09.006. Epub 2008 Sep 18.
6
Genetic polymorphism and natural selection of circumsporozoite protein in Myanmar Plasmodium vivax.缅甸间日疟原虫环子孢子蛋白的遗传多态性与自然选择
Malar J. 2020 Sep 4;19(1):303. doi: 10.1186/s12936-020-03366-7.
7
Molecular cloning and expression of the VK247 circumsporozoite protein for serodiagnosis of variant form Plasmodium vivax.VK247 环子孢子蛋白的分子克隆和表达用于间日疟变体的血清学诊断。
Parasitol Res. 2011 May;108(5):1275-82. doi: 10.1007/s00436-010-2177-3. Epub 2011 Feb 12.
8
Naturally occurring mixed infection of Plasmodium vivax VK210 and P. vivax VK247 in anopheles mosquitoes (Diptera: Culicidae) in western Thailand.泰国西部按蚊(双翅目:蚊科)中自然发生的间日疟原虫VK210和间日疟原虫VK247混合感染
J Med Entomol. 2002 May;39(3):556-9. doi: 10.1603/0022-2585-39.3.556.
9
Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil.巴西一个低发病率地区疟疾传播周期的流行病学特征
Malar J. 2007 Mar 19;6:33. doi: 10.1186/1475-2875-6-33.
10
Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population.VK210 和 VK247 人群对可溶性重组间日疟原虫环子孢子蛋白的血清学反应。
Malar J. 2013 Sep 14;12:323. doi: 10.1186/1475-2875-12-323.

引用本文的文献

1
Using Serological Markers for the Surveillance of Malaria: A Scoping Review.利用血清学标志物监测疟疾:一项范围综述
Pathogens. 2023 May 31;12(6):791. doi: 10.3390/pathogens12060791.
2
Microbial Pathogenesis in the Era of Spatial Omics.空间组学时代的微生物发病机制
Infect Immun. 2023 Jul 18;91(7):e0044222. doi: 10.1128/iai.00442-22. Epub 2023 May 31.
3
Structural basis of inhibition by antibodies binding to the circumsporozoite protein repeats.抗体结合到环子孢子蛋白重复序列的抑制作用的结构基础。
Elife. 2022 Jan 13;11:e72908. doi: 10.7554/eLife.72908.
4
Genetic diversity of Plasmodium Vivax in South of Iran: A cross-sectional study.伊朗南部间日疟原虫的遗传多样性:一项横断面研究。
J Med Life. 2015;8(Spec Iss 2):14-18.
5
Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera.间日疟原虫环子孢子蛋白重组嵌合体诱导多功能广泛反应性T细胞应答
Infect Immun. 2015 Sep;83(9):3749-61. doi: 10.1128/IAI.00480-15. Epub 2015 Jul 13.
6
Genetic diversity of Plasmodium vivax population before elimination of malaria in Hainan Province, China.中国海南省疟疾消除前间日疟原虫种群的遗传多样性。
Malar J. 2015 Feb 14;14:78. doi: 10.1186/s12936-015-0545-2.
7
Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors.间日疟原虫亚显微感染的系统评价:患病率及决定因素
PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3413. doi: 10.1371/journal.pntd.0003413. eCollection 2015 Jan.
8
A study on relapse/re-infection rate of Plasmodium vivax malaria and identification of the predominant genotypes of P. vivax in two endemic districts of Nepal.一项关于尼泊尔两个疟疾流行地区间日疟原虫复发/再感染率以及优势虫株基因型鉴定的研究。
Malar J. 2013 Sep 16;12:324. doi: 10.1186/1475-2875-12-324.
9
Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population.VK210 和 VK247 人群对可溶性重组间日疟原虫环子孢子蛋白的血清学反应。
Malar J. 2013 Sep 14;12:323. doi: 10.1186/1475-2875-12-323.
10
Molecular epidemiology of Plasmodium vivax in Latin America: polymorphism and evolutionary relationships of the circumsporozoite gene.拉丁美洲间日疟原虫的分子流行病学:环子孢子蛋白基因的多态性和进化关系。
Malar J. 2013 Jul 15;12:243. doi: 10.1186/1475-2875-12-243.

本文引用的文献

1
Review of the anopheline mosquitoes of Myanmar.缅甸按蚊综述。
J Vector Ecol. 2004 Jun;29(1):21-40.
2
Genetic diversity and multiple infections of Plasmodium vivax malaria in Western Thailand.泰国西部间日疟原虫疟疾的遗传多样性和多重感染
Am J Trop Med Hyg. 2003 May;68(5):613-9. doi: 10.4269/ajtmh.2003.68.613.
3
Naturally occurring mixed infection of Plasmodium vivax VK210 and P. vivax VK247 in anopheles mosquitoes (Diptera: Culicidae) in western Thailand.泰国西部按蚊(双翅目:蚊科)中自然发生的间日疟原虫VK210和间日疟原虫VK247混合感染
J Med Entomol. 2002 May;39(3):556-9. doi: 10.1603/0022-2585-39.3.556.
4
Variants of the Plasmodium vivax circumsporozoite protein (VK210 and VK247) in Colombian isolates.哥伦比亚分离株中间日疟原虫环子孢子蛋白的变体(VK210和VK247)
Mem Inst Oswaldo Cruz. 2001 Jul;96(5):709-12. doi: 10.1590/s0074-02762001000500023.
5
The neglected burden of Plasmodium vivax malaria.间日疟原虫疟疾被忽视的负担
Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):97-106. doi: 10.4269/ajtmh.2001.64.97.
6
Different prevalences of Plasmodium vivax phenotypes VK210 and VK247 associated with the distribution of Anopheles albimanus and Anopheles pseudopunctipennis in Mexico.与墨西哥白纹按蚊和伪点按蚊分布相关的间日疟原虫VK210和VK247表型的不同流行率。
Am J Trop Med Hyg. 2000 Jan;62(1):122-7. doi: 10.4269/ajtmh.2000.62.122.
7
Use of PCR/DNA probes to identify circumsporozoite genotype of Plasmodium vivax in China.应用聚合酶链反应/DNA探针鉴定中国间日疟原虫环子孢子蛋白基因型
Southeast Asian J Trop Med Public Health. 1999 Mar;30(1):20-3.
8
Differential susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to infections with coindigenous Plasmodium vivax variants VK210 and VK247 in southern Mexico.墨西哥南部白纹按蚊和伪点按蚊对本地间日疟原虫变种VK210和VK247感染的易感性差异
Infect Immun. 1999 Jan;67(1):410-2. doi: 10.1128/IAI.67.1.410-412.1999.
9
Plasmodium vivax VK247 and VK210 circumsporozoite proteins in Anopheles mosquitoes from Andoas, Peru.秘鲁安多亚斯按蚊体内的间日疟原虫VK247和VK210环子孢子蛋白
J Med Entomol. 1993 May;30(3):597-600. doi: 10.1093/jmedent/30.3.597.
10
A study of polymorphism in the circumsporozoite protein of human malaria parasites.人类疟原虫环子孢子蛋白多态性研究。
Am J Trop Med Hyg. 1994 Jan;50(1):45-51. doi: 10.4269/ajtmh.1994.50.45.